Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06453187 · ClinicalTrials.gov registry record · NA
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers
A NA study of Diabetic Foot Ulcer and Venous Leg Ulcer, sponsored by Integra LifeSciences Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 16
- Study locations
NCT06453187: Recruiting NA study of Diabetic Foot Ulcer and Venous Leg Ulcer, sponsored by Integra LifeSciences Corporation.
NCT06453187 is a NA study of Diabetic Foot Ulcer and Venous Leg Ulcer that is actively recruiting participants, run by Integra LifeSciences Corporation. The registered enrollment target is 350 participants, above the 250-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (40% higher). The trial reports 16 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06453187, a NA study of Diabetic Foot Ulcer and Venous Leg Ulcer, is actively recruiting participants, sponsored by Integra LifeSciences Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 16
- Study locations
Study Summary
The purpose of this study is to determine how well multiple CAMPs (Cellular, Acellular and Matrix-Like Products) and Standard of Care work when compared to Standard of Care alone in achieving complete closure of hard-to-heal diabetic foot and venous leg ulcers.
Conditions Studied
Interventions
- PROCEDURE Standard of Care
- DEVICE Urinary Bladder Matrix (UBM) sheet device for Venous Leg Ulcers
- DEVICE Urinary Bladder Matrix (UBM) sheet device for Diabetic Foot Ulcers
- DEVICE AmnioExcel Plus for Venous Leg Ulcers
- DEVICE AmnioExcel Plus for Diabetic Foot Ulcers
Study Locations (16)
Florida
- Alma Medical and Research Services, LLC - Hollywood
- Symphony Research - Jacksonville
- Lakeview Institute of Clinical Research, LLC - Leesburg
- Denali Health Plant City, LLC - Plant City
- Barry University Clinical Research - Tamarac
California
- Phase One Clinical Trials, Inc. - Bakersfield
- Angel City Research - Los Angeles
- Center for Clinical Research - San Francisco
Illinois
- SitePath Research - Evergreen Park
- Midwest Foot and Ankle Clinics - Hoffman Estates
Connecticut
- ClinTrial Medical Centers, PLLC - Hamden
Georgia
- Denali Health - Atlanta
Kansas
- Cheyenne County Hospital - Saint Francis
Maryland
- KUR Research, LLC - Columbia
New York
- Comprehensive Wound Healing Center, Northwell Health - Lake Success
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2024-11-18 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT06453187 shows while recruiting
NCT06453187 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 250-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (40% higher).
The record links to 2 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 5 interventions - of which Standard of Care is the first listed.
NCT06453187 lists 16 locations in 9 states (Florida, California, Illinois).
Frequently Asked Questions
What is clinical trial NCT06453187 about?
NCT06453187 is a clinical study titled "A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers". The purpose of this study is to determine how well multiple CAMPs (Cellular, Acellular and Matrix-Like Products) and Standard of Care work when compared to Standard of Care alone in achieving complete closure of hard-to-heal diabetic foot and venous leg ulcers.
What is the current status of trial NCT06453187?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2024-11-18. Estimated completion is 2026-08-31.
What conditions does trial NCT06453187 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Venous Leg Ulcer.
What interventions are being tested in trial NCT06453187?
The interventions under investigation include: Standard of Care (PROCEDURE), Urinary Bladder Matrix (UBM) sheet device for Venous Leg Ulcers (DEVICE), Urinary Bladder Matrix (UBM) sheet device for Diabetic Foot Ulcers (DEVICE), AmnioExcel Plus for Venous Leg Ulcers (DEVICE), AmnioExcel Plus for Diabetic Foot Ulcers (DEVICE).
Who is sponsoring clinical trial NCT06453187?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06453187 being conducted?
This trial has 16 study locations across California, Connecticut, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06453187's enrollment target sits among peer trials
350 7th of 67 higher than 60 of 67 other Diabetic Foot Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI